+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Needle-Free Drug Delivery Devices Market Size, Share & Trends Analysis Report By Application, By Technology (Jet Injectors, Inhaler, Transdermal Patch, Novel Needle Free), and Segment Forecasts, 2018 - 2025

  • ID: 4582067
  • Report
  • Region: Global
  • 90 pages
  • Grand View Research
1 of 5

FEATURED COMPANIES

  • 3M
  • Antares Pharma
  • INJEX Pharma AG
  • PenJet
  • PharmaJet
  • Valeritas, Inc
  • MORE
The global needle-free drug delivery device market size is poised to reach USD 16.27 billion by 2025, at a CAGR of 10.5% during the forecast period. Rising usage of injections in healthcare settings such as hospitals, clinics, and ambulatory surgical centers has led to spread of infectious diseases such as Hepatitis B, Hepatitis C, and AIDS, especially in developing countries. This acts as a key driver for the needle-less drug delivery devices industry. Furthermore, rising collaborations between market players is further likely to increase competitiveness of this market. For instance, PharmaJet and Mundipharma entered into a partnership in 2018 for distributing its needle free injectors over 120 markets globally.

Moreover, technological advancements in healthcare are expected to open new avenues for market players in applications such as cancer, AIDS, and Ataxic Cerebral Palsy. For instance, polycarbonate materials are being utilized in needle free injectors owing to their advantages such as design flexibility, toughness, light weight, and process ability. The most recent example of such technology is needle-free injection insulin delivery device manufactured by QS Medical Technology Co. (QS) in September 2018.

Further key findings from the report suggest:
  • Novel needle-less devices accounted for a significant share of more than 25.00% in 2017 owing to their wide array of applications
  • Based on applications, the vaccine delivery segment is estimated to exhibit a lucrative growth rate over the forecast period due to its increasing usage for pediatric patients
  • North America held the dominant share in the global arena in 2017, due to favorable government insurance policies and increased investments in R&D by healthcare companies
  • For instance, In May 2018, U.S. Congress approved “right to try” bill where patients can try unproven medical treatments and devices in case of serious illness such as orphan diseases, including NETs
  • The Asia Pacific needle-free medication transportation devices industry is anticipated to witness significant growth during the same period due to rising healthcare expenditure and growing investments by many companies in the healthcare sector
  • Additionally, several countries in this region are implementing laws that cater to adoption of medical devices. For instance, the Korea-U.S. Free Trade Agreement (KORUS FTA) was implemented on March 15, 2012, in which most of the medical devices in Korea were made duty free
  • Some of the key companies present in the market are Antares Pharma; Injex Pharma Ag; Verdict Media Limited; Valeritas, Inc.; and 3M Company
  • Industry participants are involved in extensive research activities to develop novel needless drug delivery injectors for applications such as pain management, insulin drug delivery, and vaccines delivery.


Please Note: This report will be delivered within 2 business days of ordering.

 
Please Note: This report will be delivered within 2 business days of ordering.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3M
  • Antares Pharma
  • INJEX Pharma AG
  • PenJet
  • PharmaJet
  • Valeritas, Inc
  • MORE
Chapter 1 Report Scope
1.1 Segment Market Scope
1.2 Regional Scope
1.3 Estimates & Forecast Timeline

Chapter 2 Research Methodology
2.1 Model Details
2.1.1 Regression and variable analysis
2.1.2 Total addressable market (TAM)
2.2 Information Procurement
2.3 List Of Primary Sources
2.3.1 Purchased database:
2.3.2 Internal database
2.4 Primary Interview Breakup
2.4.1 Data for primary interviews, by sources
2.4.2 Data for primary interviews, by region
2.5 List Of Secondary Sources

Chapter 3 Report Objectives
3.1 Objectives

Chapter 4 Executive Summary
4.1 Market Summary

Chapter 5 Needle-Free Drug Delivery Devices Market: Industry Outlook
5.1 Market Variable Analysis
5.2 Market Driver Analysis
5.2.1 Increasing incidences of infectious diseases
5.2.2 Rising need of self-administration of the drug
5.2.3 Introduction of technologically advanced needle-free drug delivery devices
5.2.4 High demand for pain-free delivery
5.3 Market Restraints Analysis
5.3.1 High cost of needle-free technology
5.4 Business Environment Analysis Tools
5.4.1 Needle-Free Drug Delivery Devices Market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
5.4.2 Porter’s Five Forces Analysis

Chapter 6 Competitive & Vendor Landscape
6.1 Market Participation Categorization
6.1.1 Market leader
6.1.2 Innovators
6.2 Strategic Initiatives & Outcome Analysis

Chapter 7 Needle-Free Drug Delivery Devices Market: Technology Analysis
7.1 Technology Business Analysis
7.2 Jet Injectors
7.2.1 jet injectors estimates and forecasts, 2014 - 2025 (USD Million)
7.3 Inhaler technology
7.3.1 Inhaler technology market estimates and forecasts, 2014 - 2025 (USD Million)
7.4 Transdermal Patch Technology
7.4.1 Transdermal Patch Technology market estimates and forecasts, 2014 - 2025 (USD Million)
7.5 Novel Needle-Free Technologies
7.5.1 Novel Needle-Free Technologies market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 8 Needle-Free Drug Delivery Devices Market: Application Analysis
8.1 Application Business Analysis
8.2 Vaccine Delivery
8.2.1 Vaccine Delivery estimates and forecasts, 2014 - 2025 (USD Million)
8.3 Pain Management
8.3.1 Pain Management market estimates and forecasts, 2014 - 2025 (USD Million)
8.4 Insulin Delivery
8.4.1 Insulin Delivery Technology market estimates and forecasts, 2014 - 2025 (USD Million)
8.5 Pediatric Injections
8.5.1 Pediatric Injections market estimates and forecasts, 2014 - 2025 (USD Million)
8.6 Others
8.6.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 9 Needle-Free Drug Delivery Devices Market: By Technology, By Application, and Regional Analysis
9.1 North America
9.1.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.1.2 U.S.
9.1.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.1.3 Canada
9.1.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.2 Europe
9.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.2.2 Germany
9.2.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.2.3 U.K.
9.2.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.3 Asia Pacific
9.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.3.2 China
9.3.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.3.3 India
9.3.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.3.4 Japan
9.3.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.4 Latin America
9.4.1 Market Estimates And Forecasts, 2014 - 2025 (Usd Million)
9.4.2 Mexico
9.4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.4.3 Brazil
9.4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.5 MEA
9.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
9.5.2 South Africa
9.5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 10 Company Profiles
10.1 Key Company Profiles
10.1.1 Antares Pharma
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 INJEX Pharma AG
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 Verdict Media Limited
10.1.3.1 Company overview
10.1.3.2 Product benchmarking
10.1.3.3 Strategic initiatives
10.1.4 3M
10.1.4.1 Company overview
10.1.4.2 Product benchmarking
10.1.4.3 Strategic initiatives
10.1.5 PharmaJet
10.1.5.1 Company overview
10.1.5.2 Product benchmarking
10.1.5.3 Strategic initiatives
10.1.6 zonenix
10.1.6.1 Company overview
10.1.6.2 Product benchmarking
10.1.6.3 Strategic initiatives
10.1.7 Inovio Pharmaceuticals, Inc.
10.1.7.1 Company overview
10.1.7.2 Product benchmarking
10.1.7.3 Strategic initiatives
10.1.8 Valeritas, Inc.
10.1.8.1 Company overview
10.1.8.2 Product benchmarking
10.1.8.3 Strategic initiatives
10.1.9 PenJet
10.1.9.1 Company overview
10.1.9.2 Product benchmarking
10.1.9.3 Strategic initiatives

Chapter 11 Recommendations/Conclusion
11.1 Recommendations
11.2 Conclusion
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Antares Pharma
  • INJEX Pharma AG
  • Verdict Media Limited
  • 3M
  • PharmaJet
  • zonenix
  • Inovio Pharmaceuticals, Inc.
  • Valeritas, Inc
  • PenJet
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4582067
Adroll
adroll